Shares of SunOpta Inc. (NASDAQ:STKL – Get Free Report) (TSE:SOY) have earned a consensus recommendation of “Buy” from the four analysts that are presently covering the stock, Marketbeat reports. Four equities research analysts have rated the stock with a buy rating. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $9.25.
Separately, StockNews.com raised shares of SunOpta from a “sell” rating to a “hold” rating in a research note on Saturday.
Check Out Our Latest Stock Report on STKL
Hedge Funds Weigh In On SunOpta
SunOpta Trading Down 1.3 %
Shares of NASDAQ STKL opened at $5.46 on Wednesday. The company has a quick ratio of 0.63, a current ratio of 1.22 and a debt-to-equity ratio of 1.39. SunOpta has a 1-year low of $2.79 and a 1-year high of $7.59. The business has a 50-day moving average of $5.58 and a 200-day moving average of $5.96.
SunOpta (NASDAQ:STKL – Get Free Report) (TSE:SOY) last released its quarterly earnings results on Wednesday, May 8th. The company reported $0.02 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.02. The firm had revenue of $182.80 million during the quarter, compared to analysts’ expectations of $168.87 million. SunOpta had a positive return on equity of 2.50% and a negative net margin of 24.00%. SunOpta’s quarterly revenue was up 17.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.05 EPS. As a group, equities analysts anticipate that SunOpta will post 0.13 EPS for the current year.
About SunOpta
SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.
Read More
- Five stocks we like better than SunOpta
- Using the MarketBeat Stock Split Calculator
- 3 Insider-Buy Stocks to Add to Your Watchlist Now
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Commvault Stock: AI Cybersecurity Giant Ready to Double Again
- 3 Warren Buffett Stocks to Buy Now
- Intuit Stock Ready to Soar: RBC Sees Big Upside with GenAI
Receive News & Ratings for SunOpta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SunOpta and related companies with MarketBeat.com's FREE daily email newsletter.